All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: Immunoblastic Lymphadenopathy-35740565
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 35740565 A176S
BBRF2
BBRF2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
2 35740565 S542N
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
3 35740565 A290D
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
4 35740565 V479I
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
5 35740565 P486S
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
6 35740565 P580T
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
7 35740565 S587R
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
8 35740565 A762V
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
9 35740565 N797S
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
10 35740565 S861C
BNRF1
BNRF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
11 35740565 A206S
BZLF1
BZLF1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
12 35740565 E16Q
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
13 35740565 G18E
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
14 35740565 E24D
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
15 35740565 G27S
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
16 35740565 T85A
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
17 35740565 V70A
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
18 35740565 Q74P
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
19 35740565 T585P
EBNA-1
EBNA-1
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
20 35740565 R163G
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
21 35740565 Q185R
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
22 35740565 M196I
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
23 35740565 T204S
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
24 35740565 H316N
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
25 35740565 E476G
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
26 35740565 P478S
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
27 35740565 S485P
EBNA-2
EBNA-2
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
28 35740565 H88N
EBNA-LP
EBNA-LP
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
29 35740565 H88Q
EBNA-LP
EBNA-LP
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
30 35740565 H88R
EBNA-LP
EBNA-LP
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
31 35740565 V94E
EBNA-LP
EBNA-LP
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
32 35740565 V101I
EBNA-LP
EBNA-LP
Immunoblastic Lymphadenopathy
Cell line
G
R
S
C
L
View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.